NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,696,000 | -5.4% | 21,482 | -1.2% | 2.28% | +1.8% |
| Q2 2016 | $1,793,000 | +14.6% | 21,732 | +0.6% | 2.24% | +13.9% |
| Q1 2016 | $1,565,000 | -15.7% | 21,607 | +0.2% | 1.96% | -17.0% |
| Q4 2015 | $1,856,000 | -8.9% | 21,567 | -2.7% | 2.36% | -14.3% |
| Q3 2015 | $2,037,000 | -30.6% | 22,162 | -25.7% | 2.76% | -17.4% |
| Q2 2015 | $2,934,000 | -0.9% | 29,833 | -0.7% | 3.34% | +1.4% |
| Q1 2015 | $2,962,000 | +5.1% | 30,033 | -1.2% | 3.29% | +2.7% |
| Q4 2014 | $2,817,000 | -1.4% | 30,407 | +0.1% | 3.20% | -3.4% |
| Q3 2014 | $2,857,000 | +2.1% | 30,362 | -1.7% | 3.32% | +5.0% |
| Q2 2014 | $2,797,000 | +4.4% | 30,897 | -2.0% | 3.16% | -0.3% |
| Q1 2014 | $2,680,000 | +5.1% | 31,527 | -0.6% | 3.17% | +8.6% |
| Q4 2013 | $2,549,000 | +0.5% | 31,722 | -4.0% | 2.92% | -7.3% |
| Q3 2013 | $2,536,000 | +3.4% | 33,059 | -4.7% | 3.15% | +3.3% |
| Q2 2013 | $2,453,000 | – | 34,699 | – | 3.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newman Dignan & Sheerar, Inc. | 3,739 | $353,074,000 | 56.77% |
| Susquehanna International Securities, Ltd. | 118,837 | $11,222,000 | 8.15% |
| MANAGED ASSET PORTFOLIOS, LLC | 336,762 | $31,800,000 | 5.59% |
| Martin Investment Management, LLC | 169,019 | $15,960,000 | 5.10% |
| SCHARF INVESTMENTS, LLC | 1,197,539 | $113,083,000 | 4.26% |
| GARLAND CAPITAL MANAGEMENT INC | 50,705 | $4,788,000 | 4.06% |
| Mawer Investment Management Ltd. | 6,625,594 | $625,655,000 | 3.69% |
| SPHERA FUNDS MANAGEMENT LTD. | 429,000 | $40,510,000 | 3.60% |
| First Fiduciary Investment Counsel, Inc. | 196,693 | $18,574,000 | 3.48% |
| PROFESSIONAL ADVISORY SERVICES INC | 227,971 | $21,527,000 | 3.46% |